Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply.
Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA. Larsen TL, et al. Among authors: torfoss d. J Thromb Haemost. 2022 Aug;20(8):1937-1939. doi: 10.1111/jth.15774. J Thromb Haemost. 2022. PMID: 35859282 Free article. No abstract available.
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up.
Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA. Larsen TL, et al. Among authors: torfoss d. J Thromb Haemost. 2022 May;20(5):1166-1181. doi: 10.1111/jth.15666. Epub 2022 Feb 20. J Thromb Haemost. 2022. PMID: 35114046 Free article. Clinical Trial.
Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial.
Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S. Torfoss D, et al. Clin Microbiol Infect. 2017 Mar;23(3):179-187. doi: 10.1016/j.cmi.2016.10.019. Epub 2016 Oct 26. Clin Microbiol Infect. 2017. PMID: 27793737 Free article. Clinical Trial.
Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial.
Torfoss D, Høiby EA, Tangen JM, Holte H, Bø K, Meyer P, Grøttum K, Weyde K, Lauritzsen GF, Sandstad B, Jacobsen AB, Olsen H, Kvaløy S. Torfoss D, et al. J Antimicrob Chemother. 2007 Apr;59(4):711-7. doi: 10.1093/jac/dkm003. Epub 2007 Feb 27. J Antimicrob Chemother. 2007. PMID: 17327294 Clinical Trial.
[Penicillin and aminoglycoside in febrile neutropenia].
Torfoss D, Høiby EA, Holte H, Kvaløy S. Torfoss D, et al. Tidsskr Nor Laegeforen. 2008 Dec 4;128(23):2738-40. Tidsskr Nor Laegeforen. 2008. PMID: 19079423 Free article. Review. Norwegian.
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily.
Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S. Torfoss D, et al. Scand J Immunol. 2011 Dec;74(6):632-9. doi: 10.1111/j.1365-3083.2011.02618.x. Scand J Immunol. 2011. PMID: 21883353 Free article. Clinical Trial.
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment.
Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordøy T, Dudman S, Kilander A, Wader KF, Ostenstad B, Ekanger R, Meyer P, Kolstad A. Yri OE, et al. Among authors: torfoss d. Blood. 2011 Dec 22;118(26):6769-71. doi: 10.1182/blood-2011-08-372649. Epub 2011 Nov 4. Blood. 2011. PMID: 22058114 Free article.
23 results